Inside Pharma’s Digital Shift: The Talent Powering the Transformation
Because digital is no longer a future ambition – it is a present priority In pharma, digital transformation is no longer experimental. It is strategic. From AI-driven target discovery to decentralised trials and real-world evidence platforms, global pharma companies are investing heavily in digital tools designed to accelerate R&D, reduce costs and improve outcomes. But […]
Inside Investor-Led Growth: How Capital Shapes Life Sciences Hiring
Because investment reshapes everything – especially the team In life sciences, capital is more than fuel. It is a signal. A shift. A strategic accelerant. When private equity or venture capital enters the picture, priorities evolve. Milestones tighten. Visibility increases. And suddenly, every hire has new weight. At Axion, we partner with VC-backed biotech and […]
Inside the CRO/CDMO Search: Why These Hires Demand More Than Technical Talent
Because hiring for CRO/CDMOs requires more than just industry knowledge In outsourced life sciences models, talent needs to do more than deliver technically. They need to serve, adapt and scale under pressure. Whether it’s a global CDMO bringing a product to clinic or a CRO running multi-site studies, the stakes are high. Clients expect speed. […]
Who We Work With: Inside the Ecosystem Axion Supports
Because building the right team starts with understanding the science behind the strategy In life sciences, recruitment is not about filling roles. It is about enabling breakthroughs. Every organisation we support, whether they are developing a novel therapy, scaling a platform technology or managing a complex trial, needs people who can operate at the intersection […]
Inside the Biotech CV Shortlist: What Hiring Managers Really Want
Because landing the right role starts long before the interview In biotech, your CV is not just a list of qualifications – it is your first chance to show strategic value, technical depth, and cultural fit. Hiring managers move quickly. Whether they are scaling an R&D team, launching a clinical programme, or preparing for regulatory […]